NCT07147751View on ClinicalTrials.gov

Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic Approach

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

April 30, 2026

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions

Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL)

Trial Locations (2)

6500

Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona

27100

Fondazione IRCCS Policlinico San Matteo Pavia, Pavia

All Listed Sponsors

lead

International Extranodal Lymphoma Study Group (IELSG)

OTHER

NCT07147751 - Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic Approach | Biotech Hunter | Biotech Hunter